New hope for blood cancer patients without a perfect donor match
NCT ID NCT03850366
Summary
This study is testing a modified stem cell transplant procedure for adults with blood cancers who do not have a perfectly matched donor. It uses a partially matched (haploidentical) family donor and adds a drug called bortezomib to the standard regimen. The main goal is to see how well the donor's cells take hold (engraft) and to reduce the risk of a serious complication called graft-versus-host disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Henry Ford hospital
RECRUITINGDetroit, Michigan, 48202, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.